Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
Lin Li(Tianjin Medical University Cancer Institute and Hospital), Shirong Cai(Agency for Science, Technology and Research)
Cited by 19
Related Papers
Cohort Profile: Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study
|International Journal of Epidemiology|2013|523
Small-molecule activation of the TRAIL receptor DR5 in human cancer cells
|Nature Chemical Biology|2012|129
tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets
|Cell Proliferation|2021|125
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
|Frontiers in Oncology|2023|110
Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair
|Journal of Biological Chemistry|2017|86